Instil Bio Q2 Adj. EPS $(2.88) Misses $(2.50) Estimate, Cash, Cash Equivalents, Restricted Cash, Marketable Securities And Long-term Investments Of $103.6M Will Enable The Company To Fund Its Operating Plan Beyond 2026<blockquote>Instil Bio第二季度调整后每股收益(2.88)美元低于预期(2.50)美元,1.036亿美元的现金、现金等价物、限制性现金、有价证券和长期投资将使公司能够为2026年以后的运营计划提供资金</blockquote>